دورية أكاديمية

Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy

التفاصيل البيبلوغرافية
العنوان: Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy
المؤلفون: S. Bowler, C. Siriwardhana, B. L. Mitchell, M. L. D’Antoni, D. Ogata-Arakaki, S. Souza, R. Yee, L. M. A. Gangcuangco, D. C. Chow, L. C. Ndhlovu, C. Shikuma
المصدر: HIV Research & Clinical Practice, Vol 20, Iss 4-5, Pp 123-129 (2019)
بيانات النشر: Taylor & Francis Group, 2019.
سنة النشر: 2019
المجموعة: LCC:Infectious and parasitic diseases
مصطلحات موضوعية: hiv, inflammation, fibrosis, chemokines, ccr2, ccr5, Infectious and parasitic diseases, RC109-216
الوصف: Background: Chronic HIV is associated with increased inflammation and tissue fibrosis despite suppressive antiretroviral therapy (ART). Monocytes and macrophages have been implicated in the pathogenesis of fibrosis, facilitated by chemokine receptor interactions. Methods: We assessed systemic fibrotic biomarkers (transforming growth factor beta-1 [TGF-β1], thrombospondin-1 [TSP-1], C-terminal pro-peptide of collagen type I [CICP], and IL-11) in banked plasma from a previously published 24-week open-label trial of cenicriviroc (CVC), a dual CCR2/CCR5 antagonist, among persons living with HIV (PLWH) on stable ART with undetectable plasma HIV RNA ( 0.05), while TSP-1 remained elevated in PLWH (p = 0.009) compared to controls. Conclusions: PLWH had higher levels of the plasma fibrotic markers TGF-β1, TSP-1, and CICP. After 24 weeks of CVC, fibrotic markers generally returned to levels comparable to HIV-uninfected controls. Dual CCR2 and CCR5 blockade may ameliorate the detrimental fibrotic events that persist in treated HIV.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2578-7470
25787489
Relation: https://doaj.org/toc/2578-7470
DOI: 10.1080/25787489.2020.1719319
URL الوصول: https://doaj.org/article/1943ada5fcc04469a972bdd3be6591bc
رقم الأكسشن: edsdoj.1943ada5fcc04469a972bdd3be6591bc
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:25787470
25787489
DOI:10.1080/25787489.2020.1719319